Cerebral aterial spasm. I. Adrenergic mechanism in experimental cerebral vasospasm.
This study demonstrates that an adrenergic mechanism plays an important role in producing the delayed cerebral vasospasm which follows subarachnoid hemorrhage. Results were as follows: 1. Experimental subarachnoid hemorrhage (SAH) was produced by injection of fresh arterial blood into the cisterna magna in cats. The cerebral vasospasm was shown angiographically to be biphasic in nature: immediate constriction lasting 1 h and marked prolonged spasm occurring between the 3rd and 5th day after SAH. The amount of noradrenaline (NA) and dopamine-beta-hydroxylase (DBH) activity decreased over a period of 24 h both within the wall of the basilar artery and in the locus ceruleus and then gradually increased, reaching a maximum on the 3rd day after SAH. 2. Topical application of spasmogenic substances (NA and blood) produced a marked constriction of the hypersensitive basilar artery on the 3rd day after SAH. 3. 6-Hydroxydopamine (6-OHDA) injection into the cisterna magna produced prolonged vasocilatation. The dilated vessel responded with mild transient constriction after the topical application of NA or fresh blood. DBH activity and NA concentration in the vessels, locus ceruleus and medial hypothalamus decreased markedly on the 3rd day after the cisternal injection of 6-OHDA. 4. Various spasmogenic substances (i.e. serotonin, NA, prostaglandins and methemoglobin) were measured in a mixture of equal volume of CSF and blood in cats. ONly the serotonin in the mixed fluid produced vasoconstriction. Spasmogenic substances decreased markedly in the mixed fluid incubated for 3 days at 37 degrees C, and none of these substances apart from methemoglobin was present in a concentration sufficient to produce constriction of vessels. 5. These results suggest that early spasm is induced by serotonin around the arteries of the cranial base, and delayed spasm might be caused by hyperreaction of cerebral vessels to spasmogenic substances such as methemoglobin, during the accumulation of excess NA in the cerebral vessel wall.
D000818:Animals; D001488:Basilar Artery / Q000187:drug effects; D001769:Blood; D001923:Brain Chemistry; D002415:Cats; D002536:Cerebral Arteries / Q000032:analysis / Q000294:innervation / Q000503:physiopathology; D004299:Dopamine beta-Hydroxylase / Q000032:analysis; D002546:Ischemic Attack, Transient / Q000209:etiology / Q000503:physiopathology*; D009638:Norepinephrine / Q000134:cerebrospinal fluid / Q000494:pharmacology; D011453:Prostaglandins / Q000134:cerebrospinal fluid / Q000494:pharmacology; D012701:Serotonin / Q000134:cerebrospinal fluid / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000503:physiopathology*
D011453:Prostaglandins; D012701:Serotonin; D004299:Dopamine beta-Hydroxylase; D009638:Norepinephrine